Levitra

Content Management by Vezine 1.3 Hosted by: ...

Wenning said Bayer wants to widen its health-care unit and would consider making acquisitions to expand its over-the-counter drug lineup – providing that targets fit Bayer's business plan.

Wenning made the remark at a news conference when asked whether Bayer would bid for Pfizer's over-the-counter division, if it were put up for sale.

Pfizer said last month it might sell or spin off the unit.

Bayer's crop science division had a slight decline in sales of less than 1 percent to 5.89 billion euros ($7.07 billion) while its MaterialScience unit, which produces and sells plastics, reported growth of 24.4 percent to 10.69 billion euros ($12.8 billion) in 2005.

Shares of Bayer were down nearly 3.8 percent to 32.52 euros ($39.08) in Frankfurt trading.

On the Net: www.bayer.com Quicklinks Restaurants Bars Hotels Autos Shopping Health Eldercare Singles Yellow Pages Free Newsletters Cell Phone Alerts Privacy Policy Guides Vegas Spas/Salon Travel Weddings Wine Old Town Baja Catering Casino Home Imp.

Golf SD North Gaslamp Sponsored Links Contact SignOnSanDiego.com Privacy...

(© 2006 The Associated Press.

All Rights Reserved.

This material may not be published, broadcast, rewritten, or redistributed.) Related Links Bayer Advertisement "Our strategic realignment toward innovation and growth has brought a sustained improvement in the Bayer group's earning power," Chief Exec Werner Wenning said.

Bayer pharmaceutical headquarters in Leverkusen, Germany (File) AP Track It!

Track names and topics in the news: Create My Own What's This?

More Business...